News

MHRA awards a positive scientific opinion for voxelotor–a once-daily tablet for the treatment of haemolytic anaemia

Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments

COVID-19 vaccine luminaries Pfizer and BioNTech study will examine data from the current booster and consider need for specific Omicron jab

The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of care sorafenib versus the use of sorafenib in isolation

Novartis UK has announced that the MHRA has given a positive scientific opinion for the investigational treatment, asciminib

Beckley Psytech leads a new project focused on addressing  psychiatric and neurological conditions through the use of psychedelic medicines.

The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to patients diagnosed with COPD.

Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC) technology enables the measurement of disease-indicating molecules in extremely low concentrations–in ten minutes or less.

New figures from Health Education England (HEE) show that the pharmacist vacancy rate in community pharmacies across England has doubled to 8% between 2017 and 2021.

Antibodies generated from only two vaccine doses offer less protection against the Omicron variant

The drug received conditional marketing authorisation in the UK from the MHRA in November

Imfinzi has shown improvements in the overall survival of patients with biliary tract cancer

NICE also aims to make strides in digital, genomic and antimicrobial technologies

Cancer Research UK announces clinical trial for most common type of lung cancer

The NHS launches world-first study investigating genetic testing for common diseases